SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 73 filers reported holding SAVARA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,376,800 | +54.1% | 4,560,000 | +90.5% | 0.09% | +61.1% |
Q1 2024 | $11,923,609 | -59.4% | 2,394,299 | -61.7% | 0.05% | -60.9% |
Q4 2023 | $29,400,408 | -28.7% | 6,255,406 | -42.7% | 0.14% | -28.5% |
Q3 2023 | $41,232,565 | +18.3% | 10,908,086 | 0.0% | 0.19% | +10.3% |
Q2 2023 | $34,851,335 | +63.8% | 10,908,086 | 0.0% | 0.18% | +50.9% |
Q1 2023 | $21,270,768 | +35.4% | 10,908,086 | +7.6% | 0.12% | +24.7% |
Q4 2022 | $15,709,190 | +2.3% | 10,134,961 | +2.3% | 0.09% | +10.7% |
Q3 2022 | $15,358,000 | +5.5% | 9,908,086 | +3.5% | 0.08% | +6.3% |
Q2 2022 | $14,557,000 | +30.6% | 9,577,273 | +12.6% | 0.08% | +46.3% |
Q1 2022 | $11,142,000 | +15.6% | 8,505,403 | +9.5% | 0.05% | +12.5% |
Q4 2021 | $9,635,000 | +7.2% | 7,770,262 | +19.3% | 0.05% | +14.3% |
Q3 2021 | $8,987,000 | -3.0% | 6,512,086 | +19.4% | 0.04% | +10.5% |
Q2 2021 | $9,269,000 | +8.0% | 5,452,086 | +32.1% | 0.04% | -11.6% |
Q1 2021 | $8,582,000 | +67.6% | 4,125,877 | -7.3% | 0.04% | +38.7% |
Q4 2020 | $5,120,000 | +5.5% | 4,452,086 | 0.0% | 0.03% | -8.8% |
Q3 2020 | $4,853,000 | -56.4% | 4,452,086 | -0.4% | 0.03% | -61.8% |
Q2 2020 | $11,133,000 | +8.8% | 4,470,964 | -7.3% | 0.09% | +1.1% |
Q1 2020 | $10,229,000 | -52.7% | 4,825,086 | 0.0% | 0.09% | -39.7% |
Q4 2019 | $21,616,000 | +132.3% | 4,825,086 | +37.4% | 0.15% | +108.6% |
Q3 2019 | $9,304,000 | +13.0% | 3,510,787 | +1.0% | 0.07% | +29.6% |
Q2 2019 | $8,236,000 | -53.9% | 3,475,000 | +43.3% | 0.05% | -59.7% |
Q1 2019 | $17,872,000 | -2.6% | 2,425,000 | 0.0% | 0.13% | -0.7% |
Q4 2018 | $18,357,000 | -32.0% | 2,425,000 | +0.3% | 0.14% | -15.1% |
Q3 2018 | $26,985,000 | +7.1% | 2,418,009 | +8.7% | 0.16% | +1.9% |
Q2 2018 | $25,187,000 | +23.0% | 2,225,000 | 0.0% | 0.16% | +9.9% |
Q1 2018 | $20,470,000 | -38.0% | 2,225,000 | 0.0% | 0.14% | -47.0% |
Q4 2017 | $33,019,000 | +58.7% | 2,225,000 | 0.0% | 0.27% | +44.9% |
Q3 2017 | $20,804,000 | +59.0% | 2,225,000 | 0.0% | 0.18% | +36.0% |
Q2 2017 | $13,083,000 | – | 2,225,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 4,980,804 | $16,026,005 | 46.25% |
NEA Management Company, LLC | 24,137,931 | $77,120,690 | 5.89% |
Bain Capital Life Sciences Investors, LLC | 11,622,598 | $37,134,201 | 3.82% |
VR Adviser, LLC | 6,351,531 | $20,293,142 | 3.24% |
Sio Capital Management, LLC | 1,010,701 | $3,229,190 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 198,139 | $633,054 | 0.43% |
FARALLON CAPITAL MANAGEMENT LLC | 10,908,086 | $34,851,335 | 0.18% |
Parkman Healthcare Partners LLC | 206,607 | $660,109 | 0.11% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,064,551 | $19,376,240 | 0.04% |
ClariVest Asset Management LLC | 242,900 | $776 | 0.04% |